ART27.13
Alternative Names: ART-2713; AZD-1940; NEO-1940Latest Information Update: 18 Nov 2025
At a glance
- Originator AstraZeneca; NEOMED; Pfizer
- Developer adMare BioInnovations; Artelo Biosciences; AstraZeneca
- Class Alkanes; Analgesics; Antiemetics; Appetite stimulants; Benzimidazoles; Cyclohexanes; Fluorinated hydrocarbons; Small molecules; Sulfonamides
- Mechanism of Action Cannabinoid receptor CB1 agonists; Cannabinoid receptor CB2 agonists
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Anorexia
- Preclinical Cachexia
- Discontinued Cancer pain; Nausea and vomiting; Neuropathic pain; Pain